• Free shipping over $99.00 using Canada Post and Same Day delivery services
    • English En
    • Français Fr
  • Free shipping over $99.00 using Canada Post and Same Day delivery services
    • English En
    • Français Fr

NEW: Instantly re-order your medical cannabis!  View your past orders and hit the “reorder” button to quickly add products to your cart!

of was added to your cart.

THC
16.5 - 20 mg/ml (18 - 21.8 mg/g)
CBD
<0.9 mg/ml (<1 mg/g)

This cannabis oil is derived from our Indica dominant Bubba Kush strain. WMMC Oils are created through a solventless cold water extraction process. These full spectrum oils are blended using organic extra virgin olive oil and organic coconut oil. With this process we’re able to preserve the rich cannabinoid and terpene profile of limonene, b-caryophyllene, linalool, b-myrcene and a-bisabolol this strain is known for. To get started, simply measure out your desired dose using the included syringe and release the oil under your tongue. 

Unless otherwise instructed by your healthcare practitioner, Health Canada recommends that patients should “start low, go slow” meaning patients should begin with a low dose and wait up to 120 minutes to assess the effects before administering an additional dose. 

In a survey of WMMC medical cannabis patients, the Bubba Kush strain was rated as the most effective strain for treating anxiety1.  Additionally, in our recently published patient-reported outcome study, high THC products were selected as being the most helpful in treating Post-Traumatic Stress Disorder and sleep disorders2 

Each 30 ml bottle of WMMC Oil will count as 6 grams towards your monthly limit 

Reference: 1. Kamal, B. S., Kamal, F., & Lantela, D. E. (2018). Cannabis and the anxiety of fragmentation—a systems approach for finding an anxiolytic cannabis chemotype. Frontiers in neuroscience12, 730. 

2. Cahill SP, Lunn SE, Diaz P and Page JE (2021) Evaluation of Patient Reported Safety and Efficacy of Cannabis from a Survey of Medical Cannabis Patients in Canada. Front. Public Health 9:626853.

Size
Size
Size
Size
Size
Size
Size
Size
Size
Size
Size
Size
Size
Size
Quantity
- +
$80.00
* To ensure availability for all patients, Bubba Kush Oil is limited to 3 bottles per order

You have reached your maximum and cannot add this item.

You have reached your order allowance limit for this product.

You have reached your maximum

You can not add anymore of this product

Your prescription has expired

Unfortunately, the THC or CBD of this product is outside your prescription limits. Please choose another product.

This product is unavailable under your prescription

Your medical document has been exhausted

Please speak to your health care provider to get a prescription to be able to purchase this product.

Back to Shop

This cannabis oil is derived from our Indica dominant Bubba Kush strain. WMMC Oils are created through a solventless cold water extraction process. These full spectrum oils are blended using organic extra virgin olive oil and organic coconut oil. With this process we’re able to preserve the rich cannabinoid and terpene profile of limonene, b-caryophyllene, linalool, b-myrcene and a-bisabolol this strain is known for. To get started, simply measure out your desired dose using the included syringe and release the oil under your tongue. 

Unless otherwise instructed by your healthcare practitioner, Health Canada recommends that patients should “start low, go slow” meaning patients should begin with a low dose and wait up to 120 minutes to assess the effects before administering an additional dose. 

In a survey of WMMC medical cannabis patients, the Bubba Kush strain was rated as the most effective strain for treating anxiety1.  Additionally, in our recently published patient-reported outcome study, high THC products were selected as being the most helpful in treating Post-Traumatic Stress Disorder and sleep disorders2 

Each 30 ml bottle of WMMC Oil will count as 6 grams towards your monthly limit 

Reference: 1. Kamal, B. S., Kamal, F., & Lantela, D. E. (2018). Cannabis and the anxiety of fragmentation—a systems approach for finding an anxiolytic cannabis chemotype. Frontiers in neuroscience12, 730. 

2. Cahill SP, Lunn SE, Diaz P and Page JE (2021) Evaluation of Patient Reported Safety and Efficacy of Cannabis from a Survey of Medical Cannabis Patients in Canada. Front. Public Health 9:626853.

You must be of legal age in your province of residence to view our content.

Go Back

  • English En
  • Français Fr
  • Better Together
Welcome to Aurora. A family of medical cannabis brands.

Patient Login

Forgot password?

This website uses cookies to enable essential features, please review our Cookie Policy for more information on how to manage and personalize your experience.